S
43.66
4.72 (12.12%)
| Previous Close | 38.94 |
| Open | 38.68 |
| Volume | 268,065 |
| Avg. Volume (3M) | 291,052 |
| Market Cap | 1,948,492,928 |
| Price / Book | 6.04 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Diluted EPS (TTM) | -1.50 |
| Total Debt/Equity (MRQ) | 2.70% |
| Current Ratio (MRQ) | 28.73 |
| Operating Cash Flow (TTM) | -55.90 M |
| Levered Free Cash Flow (TTM) | -40.48 M |
| Return on Assets (TTM) | -37.10% |
| Return on Equity (TTM) | -61.44% |
AIStockmoo Score
-0.4
| Analyst Consensus | -0.5 |
| Insider Activity | -5.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.40 |
| % Held by Insiders | 7.20% |
| % Held by Institutions | 93.91% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 50.00 (BTIG, 14.52%) | Buy |
| Median | 45.00 (3.07%) | |
| Low | 24.00 (RBC Capital, -45.03%) | Sell |
| Average | 40.60 (-7.01%) | |
| Total | 4 Buy, 1 Sell | |
| Avg. Price @ Call | 32.02 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 01 Dec 2025 | 24.00 (-45.03%) | Sell | 43.57 |
| 03 Sep 2025 | 22.00 (-49.61%) | Hold | 24.55 | |
| BTIG | 19 Nov 2025 | 50.00 (14.52%) | Buy | 38.41 |
| Freedom Capital Markets | 17 Oct 2025 | 38.00 (-12.96%) | Buy | 31.93 |
| Jones Trading | 08 Sep 2025 | 46.00 (5.36%) | Buy | 21.62 |
| Raymond James | 03 Sep 2025 | 45.00 (3.07%) | Buy | 24.55 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | 40.03 | -84,680 | -3,392,405 |
| Aggregate Net Quantity | -84,680 | |||
| Aggregate Net Value ($) | -3,392,405 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 40.03 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | 21 Nov 2025 | Sell (-) | 25,183 | 43.66 | 1,099,490 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 20 Nov 2025 | Sell (-) | 5,133 | 38.94 | 199,879 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 19 Nov 2025 | Sell (-) | 47,442 | 38.41 | 1,822,247 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 18 Nov 2025 | Sell (-) | 6,922 | 39.12 | 270,789 |
| Date | Type | Details |
|---|---|---|
| 24 Nov 2025 | Announcement | Sionna Therapeutics to Participate in Upcoming December Investor Conferences |
| 05 Nov 2025 | Announcement | Sionna Therapeutics Reports Third Quarter 2025 Financial Results |
| 04 Nov 2025 | Announcement | Sionna Therapeutics to Participate in Upcoming November Investor Conferences |
| 24 Oct 2025 | Announcement | Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference |
| 21 Oct 2025 | Announcement | Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis |
| 01 Oct 2025 | Announcement | Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference |
| 08 Sep 2025 | Announcement | Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |